Skip to main content
OpenTrials

Clinical trial condition

Hepatitis, Viral, Human

Explore clinical trials studying Hepatitis, Viral, Human. Study availability and eligibility vary by location and protocol.

2,914 public trials 161 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis, Viral, Human trial results

Completed

Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs

NCT00013871

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Blood-Borne Infections, +38 more
Locations
  • UAB, Dept. of Ped., Div. of Infectious Diseases Birmingham, Alabama, United States
  • Long Beach Memorial Med. Ctr., Miller Children's Hosp. Long Beach, California, United States
  • Usc La Nichd Crs Los Angeles, California, United States
  • Children's Hosp. & Research Ctr. Oakland, Ped. Clinical Research Ctr. & Research Lab. Oakland, California, United States
View all 40 locations
View Trial Details
Completed

Evaluating the Safety of ITX 5061 in Treatment-Naive Hepatitis C (HCV)-Infected Adults

NCT01165359

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • UCLA CARE Center CRS Los Angeles, California, United States
  • Ucsd, Avrc Crs San Diego, California, United States
  • Ucsf Aids Crs San Francisco, California, United States
View Trial Details
Completed

Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN Alfa-2b), and Ribavirin (RBV) Treatment in Patients With Hepatitis C and HIV Coinfection

NCT00015652

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +17 more
Locations
  • UCLA CARE Center CRS Los Angeles, California, United States
  • University of Colorado Hospital CRS Aurora, Colorado, United States
  • Northwestern University CRS Chicago, Illinois, United States
  • Univ. of Iowa Healthcare, Div. of Infectious Diseases Iowa City, Iowa, United States
View Trial Details
Completed

Safety and Acceptability of a Vaginal Microbicide

NCT00111943

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +24 more
Locations
  • Alabama Microbicide CRS Birmingham, Alabama, United States
  • Bronx- Lebanon Hospital Center Clinical Research Site (BLHC CRS) The Bronx, New York, United States
  • NARI Arogya Aadhar Clinic CRS Pune, Maharashtra, India
View Trial Details
Completed

A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV)

NCT00008463

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +23 more
Locations
  • Ucsd, Avrc Crs San Diego, California, United States
  • Ucsf Aids Crs San Francisco, California, United States
  • University of Colorado Hospital CRS Aurora, Colorado, United States
  • Univ. of Miami AIDS CRS Miami, Florida, United States
View all 24 locations
View Trial Details
Completed

Determining Responses to Two Different Vaccines in HIV and HCV Infected Individuals

NCT00393276

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +17 more
Locations
  • UCSD Antiviral Research Center CRS San Diego, California, United States
  • Ucsf Aids Crs San Francisco, California, United States
  • University of Colorado Hospital CRS Aurora, Colorado, United States
  • IHV Baltimore Treatment CRS Baltimore, Maryland, United States
View Trial Details
Completed

Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir (SOF/VEL) Fixed-Dose Combination (FDC) and Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX ) FDC for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) Infection

NCT04211909

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations
  • Seoul National University Bundang Hospital Seongnam-si, Gyeonggi-D, South Korea
  • Inje University Busan Paik Hospital Busan, South Korea
  • Dong-A University Hospital Busan, South Korea
  • Pusan National University Hospital Busan, South Korea
View all 22 locations
View Trial Details

Related conditions